HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA semi-annual agenda

This article was originally published in The Rose Sheet

Executive Summary

A notice of proposed rulemaking for topical antimicrobial consumer products and healthcare antiseptics is slated for release in March, according to FDA's semi-annual agenda, published in Oct. 31 Federal Register. Agency is working to finalize a tentative final monograph for topical antimicrobials published in the June 1994 Federal Register. In October, the Nonprescription Drugs Advisory Committee met to address questions regarding the safety and efficacy of consumer antimicrobials (1"The Rose Sheet" Oct. 24, 2005, p. 9). Additional items on the semi-annual agenda include an amendment to the NPRM for OTC dandruff, seborrheic dermatitis and psoriasis products in December and technical amendments to the final action for skin protectant products marketed as lip protectants in December. The agency expects to release an NPRM for skin bleaching products in March and final action for plaque gingivitis products is slated for October of next year...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013478

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel